Displayed to two decimal places.
PERSON · STARLIGHT
David Relman
Recorded name: 大卫·雷尔曼
David Relman is a microbiology and infectious-disease researcher at Stanford University.
Original Chinese introduction
大卫·雷尔曼是微生物与感染研究者,任职于斯坦福大学。
Relman studies the human microbiome, previously unrecognized microbial pathogens, and host responses in infection. His work uses molecular sequence data to study relationships between microbes and disease, and he also participates in public biosafety discussions. A sequence signal by itself cannot automatically establish that a microorganism is the cause; causal interpretation still requires independent evidence, an important limit of his research framework.
Original Chinese context
雷尔曼研究人体微生物群、此前未被识别的微生物病原体,以及感染中的宿主反应。他的工作把分子序列资料用于研究微生物与疾病之间的关系,也参与生物安全公共讨论。序列信号本身不能自动证明某微生物就是病因;因果解释仍需独立证据,这也是其研究框架的重要限制。
- Stanford School of Medicine: David Relman profile ↗Original Chinese label · 斯坦福医学院:David Relman 个人资料
- U.S. National Academy of Sciences: Relman biographical profile ↗Original Chinese label · 美国国家科学院:Relman 生平资料
- U.S. CDC: research on unrecognized microbial pathogens ↗Original Chinese label · 美国 CDC:未识别微生物病原体研究
Derived from the current score.
Contribution groups assessed so far; coverage is still being expanded.
ASSESSMENT SCOPEWhat this score covers
All included contribution titles and notes are available in English. The complete original text remains available in Chinese; both editions use the same scores and source links.
Uncovered contributions and unresolved harms are not treated as zero. This is not a complete assessment of a lifetime.
3 included contributions have incomplete evidence; the relevant gap appears with that contribution.
Original scope note
This research record currently includes 3 outcomes within a limited scope; M and attribution shares are revisable judgments. Uncovered content and negative effects not yet clarified are not treated as zero; specific gaps appear in the item-by-item explanations.
Original Chinese scope
本轮当前已列3项有限研究账;M与归功份额为可修订判断。未覆盖内容和未核清的负面作用不按零处理,具体缺口见逐项说明。
CALCULATIONHow the score is calculated
Q = 10^(M/2) − 1; Lᵢ = aᵢ × Qᵢ; L = Σ Lᵢ; S = 2 × log₁₀(1 + L).
M is an outcome’s assessed magnitude and a is the person’s allocated share. A standalone score is only a per-item reference; the attributed light from distinct contributions is what can be combined.
SCORE DETAILS
3 evaluated contributions
M is the assessed magnitude of an outcome; attribution is the person’s share of credit. Attributed light can be added. The standalone score is only a per-item reference and must not be added across rows.
Scroll sideways for scores and attribution.
| Outcome | M | Attribution share | Attributed light | Standalone score | Share of total | Status |
|---|---|---|---|---|---|---|
| 01Culture-independent molecular identification and discovery paradigm for difficult-to-culture pathogens难培养病原体的培养非依赖分子识别与发现范式OUT-SL2031-1990-1998-CULTURE-INDEPENDENT-PATHOGEN-IDENTIFICATION · 1990 | 6.1 | 22% | 246.624060 | 4.79 | 46.5257% | Provisional estimate · incomplete evidence |
| 02Ecological research on the human microbiome across space, time, and recovery from disturbance人类微生物群的空间、时间与扰动恢复生态研究OUT-SL2031-2000-2020-HUMAN-MICROBIOME-SPATIAL-TEMPORAL-ECOLOGY · 2000 | 5.8 | 20% | 158.665647 | 4.41 | 29.9323% | Provisional estimate · incomplete evidence |
| 03A molecular-criteria framework for assigning sequence evidence to pathogen causation序列证据到病原因果归属的分子判据框架OUT-SL2031-1996-1998-SEQUENCE-BASED-PATHOGEN-CAUSATION-CRITERIA · 1996 | 5.3 | 28% | 124.791406 | 4.20 | 23.5419% | Provisional estimate · incomplete evidence |
On small screens, scroll this table horizontally to reach every numeric column.
NOTES AND SOURCES
Contribution notes and source links
English translations of the included notes appear below, with their Chinese originals available for comparison.
01Culture-independent molecular identification and discovery paradigm for difficult-to-culture pathogens难培养病原体的培养非依赖分子识别与发现范式OUT-SL2031-1990-1998-CULTURE-INDEPENDENT-PATHOGEN-IDENTIFICATION
Record year1990
summaryIt used molecular phylogenetic information to identify candidate microorganisms that were difficult to culture or previously unknown, extending discovery workflows to objects conventional culture struggled to cover while making the interpretive limits of sequence evidence explicit.
Original Chinese · summary
将分子系统发育信息用于识别难以培养或此前未知的微生物候选,并把发现流程扩展到常规培养难以覆盖的对象,同时公开序列证据的解释限制。
M rationaleOriginal-paper reviews and CDC open full text support the formation of this paradigm and its use in identifying specific unknown microorganisms. M6.1 is assigned for its testable knowledge boundary, extension to difficult-to-culture objects, and methodological reuse, rather than accumulated by pathogen count or clinical consequences.
Original Chinese · M rationale
原始论文回顾与CDC开放全文支持这一范式形成并被用于具体未知微生物识别。按可检验知识边界、对难培养对象的扩展和方法复用取M6.1,而不是按病原数量或临床后果累加。
attribution rationaleRelman 0.22; Falkow 0.12; early coauthors 0.18; prior molecular methods 0.19; clinical pathology sequencing teams 0.12; institutions 0.05; unresolved 0.12.
Original Chinese · attribution rationale
Relman 0.22;Falkow 0.12;早期共同作者0.18;分子方法前史0.19;临床病理测序团队0.12;机构0.05;未解析0.12。
overlap boundaryThe knowledge and methodological outcome, represented in 1990–1998 by culture-independent molecular identification of difficult-to-culture and previously unrecognized microorganisms; it counts only the identification paradigm and knowledge increment, and does not equate sequence presence with causal pathogenicity.
Original Chinese · overlap boundary
1990–1998以难培养、此前未识别微生物的培养非依赖分子识别为代表的知识与方法终态;只计识别范式与知识增量;不把序列出现等同致病因果。
Evidence gapsAuthor order, experimental design, and independent verification for each specific discovery have not been closed paper by paper. A systematic sample of successes and failures from candidate identification to disease causation has not yet been made.
Original Chinese · evidence gaps
各具体发现的作者顺序、实验设计与独立验证未逐篇闭合。;方法从候选识别到疾病因果的成功与失败案例尚未做系统样本。
Full attribution budget
Every recorded actor remains visible. Share (0–1) retains the ledger’s exact decimal value.
- 0.22David RelmanOriginal Chinese · 大卫·雷尔曼Person
- 0.12Stanley FalkowPerson
- 0.18Relman's early pathogen-discovery coauthorsOriginal Chinese · Relman早期病原发现共同作者Team
- 0.19Precursors of molecular phylogeny and nucleic-acid methodsOriginal Chinese · 分子系统发育与核酸方法前驱Predecessor pool
- 0.12Clinical pathology sequencing and data teamsOriginal Chinese · 临床病理测序与数据团队Team
- 0.05Stanford and collaborating research institutionsOriginal Chinese · 斯坦福与合作研究机构Institution
- 0.12Unresolved Relman contributions to pathogen identificationOriginal Chinese · 未解析的Relman病原识别贡献Unallocated
Source links
- Works, papers, and institutional materials: pubmed.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pubmed.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: pmc.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pmc.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: pmc.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pmc.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: pmc.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pmc.ncbi.nlm.nih.gov
02Ecological research on the human microbiome across space, time, and recovery from disturbance人类微生物群的空间、时间与扰动恢复生态研究OUT-SL2031-2000-2020-HUMAN-MICROBIOME-SPATIAL-TEMPORAL-ECOLOGY
Record year2000
summaryUsing longitudinal, multi-site community data, it characterized individual differences, temporal change, and incomplete recovery after disturbance, treating the human microbiome more explicitly as a dynamic ecosystem.
Original Chinese · summary
以纵向和多部位群落资料刻画个体差异、时间变化及扰动后的不完全恢复,将人体微生物群更明确地作为动态生态系统研究。
M rationaleStanford research summaries and representative papers support actual research deliveries on oral communities, temporal change, and recovery from disturbance. M5.8 is assigned for establishing knowledge of dynamic human microbial ecology and a long-term methodological example, without adding credit for the label “pioneer” or imagined health applications.
Original Chinese · M rationale
Stanford研究概述与代表性论文支持对口腔群落、时间变化和扰动恢复的实际研究交付。按形成动态人体微生物生态知识和长期方法范例取M5.8,不因“先驱”称号或健康应用想象加分。
attribution rationaleRelman 0.20; Bik/Dethlefsen representative coauthors 0.16; laboratory and coauthors 0.22; prior ecology and microbiome work 0.19; institutions 0.06; unresolved 0.17.
Original Chinese · attribution rationale
Relman 0.20;Bik/Dethlefsen代表性共同作者0.16;实验室及共同作者0.22;生态与微生物群前史0.19;机构0.06;未解析0.17。
overlap boundaryResearch from 2000–2020 on community structure of the native human microbiome across body sites, individuals, and time, and on stability and recovery after disturbance; it counts only the ecological knowledge outcome, and does not equate correlation with disease cause, diagnosis, or treatment.
Original Chinese · overlap boundary
2000–2020人类原生微生物群在身体部位、个体和时间上的群落结构,以及扰动后的稳定性和恢复研究;只计生态知识终态,不把相关性等同疾病病因、诊断或治疗。
Evidence gapsThe specific coauthors and cohort contributions in different representative papers still require paper-by-paper decomposition. Causal strength among community description, disturbance mechanisms, and health associations has not been systematically calibrated. Project-by-project records are lacking for privacy, sample governance, and participants' actual research contributions.
Original Chinese · evidence gaps
不同代表性论文的具体共同作者和队列贡献仍需逐篇分解。;群落描述、扰动机制和健康关联之间的因果强度未系统校准。;隐私、样本治理和参与者实际研究贡献缺逐项目档案。
Full attribution budget
Every recorded actor remains visible. Share (0–1) retains the ledger’s exact decimal value.
- 0.2David RelmanOriginal Chinese · 大卫·雷尔曼Person
- 0.16Elisabeth Bik and Leslie DethlefsenOriginal Chinese · Elisabeth Bik与Leslie DethlefsenTeam
- 0.22Relman microbiome laboratory and coauthorsOriginal Chinese · Relman微生物组实验室与共同作者Team
- 0.19Precursors of microbial ecology and the human microbiomeOriginal Chinese · 微生物生态与人体微生物群前驱Predecessor pool
- 0.06Stanford and collaborating microbiome institutionsOriginal Chinese · 斯坦福与合作微生物组机构Institution
- 0.17Unresolved Relman microbiome contributionsOriginal Chinese · 未解析的Relman微生物组贡献Unallocated
Source links
- Works, papers, and institutional materials: pubmed.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pubmed.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: pubmed.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pubmed.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: profiles.stanford.edu ↗Original Chinese label · 作品、论文与机构资料:profiles.stanford.edu
03A molecular-criteria framework for assigning sequence evidence to pathogen causation序列证据到病原因果归属的分子判据框架OUT-SL2031-1996-1998-SEQUENCE-BASED-PATHOGEN-CAUSATION-CRITERIA
Record year1996
summaryIt organized high-level conditions such as tissue distribution, host response, consistency, reproducibility, and alternative explanations into a causal-review framework for sequence evidence, making clear that a single sequence detection is insufficient to establish causation.
Original Chinese · summary
把组织分布、宿主反应、一致性、可重复性和替代解释等高层条件组织为序列证据的因果审查框架,明确单次序列检出不足以确立病因。
M rationaleThe open review clearly distinguishes sequence detection from causal attribution, and the Fredericks–Relman framework forms an epistemic outcome different from discovery technology. M5.3 is assigned for the method's general review value; its scope is narrower than an actual discovery system and does not duplicate the latter's general detection value.
Original Chinese · M rationale
开放综述明确区分序列检出与病因归属,Fredericks–Relman框架形成与发现技术不同的认识论终态。按方法的通用审查价值取M5.3,范围窄于实际发现体系且不重复其一般检测价值。
attribution rationaleRelman 0.28; Fredericks 0.28; prior classical causality work 0.20; research-community experiential input 0.10; institutions 0.04; unresolved 0.10.
Original Chinese · attribution rationale
Relman 0.28;Fredericks 0.28;经典因果前史0.20;研究社群经验输入0.10;机构0.04;未解析0.10。
overlap boundaryCriteria and epistemic limits for attributing causation from sequence-based microbial evidence in 1996–1998; it counts only a rule framework that moves from “detected” to “conditionally supports causation,” without duplicating the preceding discovery method.
Original Chinese · overlap boundary
1996–1998序列型微生物证据的病因归属判据与认识论限制;只计从“检测到”到“有条件支持因果”的规则框架,不重复上一点的发现方法。
Evidence gapsThe early intellectual sources of each criterion and their subsequent empirical performance have not been traced item by item. Its effect in reducing false attribution across different fields has not yet been systematically compared.
Original Chinese · evidence gaps
判据各条的早期思想来源及后续实证表现未逐项追溯。;尚未系统比较其在不同研究领域的误归因减少效果。
Full attribution budget
Every recorded actor remains visible. Share (0–1) retains the ledger’s exact decimal value.
- 0.28David RelmanOriginal Chinese · 大卫·雷尔曼Person
- 0.28David N. FredricksPerson
- 0.2Koch, Rivers, and precursors of microbial causationOriginal Chinese · Koch、Rivers与微生物因果前驱Predecessor pool
- 0.1Molecular pathogen-discovery and validation research communitiesOriginal Chinese · 分子病原发现与验证研究群体Team
- 0.04Stanford research and publishing institutionsOriginal Chinese · 斯坦福研究与出版机构Institution
- 0.1Unresolved contributions to molecular causation criteriaOriginal Chinese · 未解析的分子因果判据贡献Unallocated
Source links
- Works, papers, and institutional materials: pmc.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pmc.ncbi.nlm.nih.gov
- Works, papers, and institutional materials: pmc.ncbi.nlm.nih.gov ↗Original Chinese label · 作品、论文与机构资料:pmc.ncbi.nlm.nih.gov
BOUNDARIES NOT COUNTED
Not included in this score
These subjects are recorded as exclusions and are not silently treated as zero or as part of the included outcomes.
Host gene-expression responses and early infection research
宿主基因表达反应与感染早期研究
Reason Institutional profiles establish the research direction, but this package lacks the main papers, coauthors, and mutually exclusive outcome relative to the pathogen-identification/microbiome entries; no M is set from a directional description alone.
Original Chinese reason
机构简介证明研究方向,但现包缺主要论文、共同作者和与病原识别/微生物组点的互斥终态,暂不凭方向描述设M。
Biosafety committees and scientific advisory service
生物安全委员会与科学咨询服务
Reason Founding membership and committee positions can be evidenced, but there are no specific signed reports, votes, rule texts, or adopted deliveries; a position itself receives no positive M. Potential governance benefits and constraints both remain unknown.
Original Chinese reason
可证创始成员及委员会职位,但未给具体署名报告、表决、规则文本或被采纳交付;职位本身不设正向M。潜在治理收益与限制均保持未知。
How to read this score
Scores can change when evidence is reviewed. The method page explains how magnitude, attribution, and included results relate to the displayed score.
Read the method in English →